During
the aging of the human body, soft tissues such as joints and intervertebral
discs are more prone to problems. Current treatments usually use materials such
as metal and plastic to implant into the body to repair or replace damaged soft
tissue.
Jianyu
Li, an assistant professor in the Department of Mechanical Engineering at
McGill University in Canada, has adopted transdisciplinary approaches with his
team by synergizing principles in mechanics, chemistry, biomimetics and bioengineering to invent novel biomaterials with unprecedented properties. His achievements
include high-strength bio-glue used to replace surgical sutures to close wounds,
high-performance bionic implant materials used for articular cartilage and disc
repair, and new hemostatic materials used to control major bleeding.
These
achievements outperform any existing materials and could improve and enable
broad biomedical applications, including strong tissue adhesives to replace
sutures and staples, biomimetic implants for cartilage and intervertebral disc
repair, and life-saving technology to treat hemorrhage and bleeding
complications.
Jianyu
Li received his bachelor's degree from Zhejiang University and his Ph.D. from
Harvard University. For his post-doctoral degree, Jianyu Li turned to the field
of biological materials and biological engineering.
His
unique learning process gives him an interdisciplinary background. Through his research, he is it able to develop new materials from an unconventional
perspective and method, including studying the nature of biological tissue itself
from the perspective of bionics and creating new materials in a
multidisciplinary way to reshape the nature of biological tissue itself to meet actual biomedical needs.
In
Jianyu Li's mind, it has been nine years since the beginning of his doctoral
career, and his research work has been approaching, step by step, the final practical
application from the basic research since the beginning. At
this stage, Jianyu Li and his team are focusing on the optimization and
preclinical testing of these new biomaterials. For the next milestone,
they want to push the material technology to clinical transformation and
commercial application.
